SUBSCRIBERS
Peter Lim to inject healthcare assets into Rowsley
Published Tue, Jul 18, 2017 · 09:50 PM
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
REAL estate and investment firm Rowsley said on Tuesday night that controlling shareholder, Singapore billionaire Peter Lim, will be injecting his 100 per cent stake in Thomson Medical Pte Ltd and 70.36 per cent stake in Bursa Malaysia-listed TMC Life Sciences (TMCLS) into the firm.
The proposed acquisitions are valued at up to S$1.9 billion, and will be financed through up to 25.3 billion consideration shares issued by Rowsley to Mr Lim at S$0.075 a share.
Copyright SPH Media. All rights reserved.